Developments in drug delivery: implications for cancer care.

Area of Science:

• Oncology
• Pharmacology
• Drug Delivery Systems

Background:

• Cancer care has been significantly influenced by drug delivery and development over the last two decades.
• Modified-release drugs and new drug delivery routes are now integral to standard cancer treatment protocols.

Purpose of the Study:

• To review the impact of drug delivery and development on cancer care.
• To highlight strategies for enhancing anti-tumor drug selectivity.
• To discuss the role of fixed drug combinations in cancer supportive care.

Main Methods:

• Review of recent advancements in drug delivery and formulation.
• Analysis of strategies for targeted drug delivery to tumors (e.g., antibodies, liposomes, homing molecules).
• Examination of the application of fixed drug combinations in supportive cancer care.

Main Results:

• Modified-release formulations and novel delivery routes are established in cancer therapy.
• Targeting strategies using antibodies, liposomes, and tumor-activated carriers improve drug selectivity.
• Fixed drug combinations show promise in supportive cancer care settings.

Conclusions:

• Drug delivery innovations and new drug development continue to reshape cancer treatment paradigms.
• Targeted delivery systems offer enhanced anti-tumor efficacy and reduced systemic toxicity.
• Fixed drug combinations represent a valuable approach for managing cancer and its associated symptoms.